Skip to main content
logo
iSERA Lifesciences Limited (BOM:534920)
India flag India · Delayed Price · Currency is INR
143.90
0.00 (0.00%)
At close: Sep 30, 2026

iSERA Lifesciences Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
13.5513.552.65---
Revenue Growth
410.94%410.94%----
Gross Profit
8.819.042.65---
Operating Income
-0.412.81.39-0.99-1.16-1.06
Net Income
-0.612.591.18-0.94-1.12-1.06
Earnings Per Share
-0.290.313.65-3.14-3.73-
EPS Growth
--91.55%----

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
28.6628.660.210.010.030.01
Total Debt
16.6316.6316.061.841.25-
Net Cash (Debt)
12.0312.03-15.85-1.83-1.220.01
Net Cash Growth
------
Net Cash Per Share
5.731.43-48.98-6.10-4.08-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--53.54-14.02-0.61-1.23-3
Capital Expenditures
------
Free Cash Flow
--53.54-14.02-0.61-1.23-3
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
65.03%66.74%100.00%---
Operating Margin
-3.03%20.64%52.38%---
Pretax Margin
1.15%24.83%52.38%---
Profit Margin
-4.53%19.14%44.53%---
FCF Margin
--395.14%-528.54%---

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
-178.81185.31---
PS Ratio
89.3034.2382.52---